High risk-factor level and low risk-factor knowledge in patients not accessing cardiac rehabilitation after acute coronary syndrome

Medical Journal of Australia

Volumn 186, Issue 1, 2007, Pages 21-25

  Redfern, Julie ^a   Ellis, Elizabeth R ^a   Briffa, Tom ^b   Freedman, S Ben ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIANGINA PECTORIS AGENT; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; AWARENESS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HEALTH CARE UTILIZATION; HEART REHABILITATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SHORT FORM 36; TERTIARY HEALTH CARE;

EID: 33846323629     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2007.tb00783.x     Document Type: Article

References (25)

1. Australian Institute of Health and Welfare. Heart, stroke and vascular diseases, Australian facts 2004. Cardiovascular disease series No. 22. Canberra: AIHW, 2004. (AIHW Catalogue No. CVD 27.)
2. Acute Coronary Syndrome Guidelines Working Group. Guidelines for the management of acute coronary syndromes 2006. Med J Aust 2006; 184 (8 Suppl): S1-S32.
3. McAlister FA, Lawson FME, Teo KK, Armstrong PW. Randomised trials of secondary prevention programs in coronary heart disease: systematic review. BMJ 2001; 323: 957-962.
4. Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: a systematic review and metaanalysis of randomized trials. Am J Med 2004; 116: 682-697.
5. Bunker S, McBurney H, Cox H, Jelinek M. Identifying participation rates at outpatient cardiac rehabilitation programs in Victoria, Australia. J Cardiopulm Rehabil 1999; 19: 334-338.
6. Scott IA, Lindsay KA, Harden HE. Utilisation of outpatient cardiac rehabilitation in Queensland. Med J Aust 2003; 179: 341-345.
7. Evenson KR, Fleury J. Barriers to outpatient cardiac rehabilitation participation and adherence. J Cardiopulm Rehabil 2000; 20: 241-246.
8. Harlan WR, Sandler SA, Lee KL, et al. Importance of baseline functional and socioeconomic factors for participation in cardiac rehabilitation. Am J Cardiol 1995; 76: 36-39.
9. Sundararajan V, Bunker SJ, Begg S, et al. Attendance rates and outcomes of cardiac rehabilitation in Victoria, 1998. Med J Aust 2004; 180: 268-271.
10. Czar M, Engler M. Perceived learning needs of patients with coronary artery disease using a questionnaire assessment tool. Heart Lung 1997; 26: 109-117.
11. Alm-Roijer C, Stagmo M, Uden G, Erhardt L. Better knowledge improves adherence to lifestyle changes and medication in patients with-coronary heart disease. Eur J Cardiovasc Nurs 2004; 3: 321-330.
12. Brody DS, Miller SM, Lerman CE, et al. Patient perception of involvement in medical care: relationship to illness attitudes and outcomes. J Gen Intern Med 1989; 4: 506-511.
13. Momtahan K, Berkman J, Sellick J, et al. Patients' understanding of cardiac risk factors: a point-prevalence study. J Cardiovasc Nurs 2004; 19: 13-20.
14. Commonwealth Department of Health and Ageing. Australian refined diagnosis related groups (AR-DRGs). AR-DRGs version 4.1 (Vol 1). Canberra: The Department, 1998. http://www.health.gov.au/internet/wcms/ publishing.nsf/Content/health-casemix-ardrg1.htm (accessed Oct 2006).
15. El Assaad MA, Topouchian J, Asmar RG. Evaluation of two devices for self-measurement of blood pressure according to the international protocol: the Omron MS-I and the Omron 705IT. Blood Press Monit 2003; 8: 127-133.
16. Cunningham A J, Hormbrey R Breath analysis to detect recent exposure to carbon monoxide. Postgrad Med J 2002; 78: 233-237.
17. Booth M. Assessment of physical activity: an international perspective. Res Q Exerc Sport 2000; 71: S114-S120.
18. Hare DL, Davis CR. Cardiac depression scale: validation of a new depression scale for cardiac patients. J Psychosom Res 1996; 40: 379-386.
19. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF36). I: Conceptual framework and item selection. Med Care 1992; 30: 473-483.
20. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36® health survey manual and interpretation guide 1993. Boston, MA: New England Medical Center, The Health Institute, 1993.
21. Australian Bureau of Statistics. 1996 Census of population and housing: socio-economic indexes for areas (SEIFA), Australia. Canberra: ABS, 1998. (Catalogue No. 2033.0.30.001.)
22. Marschner IC, Colquhoun D, Simes RJ, et al. Long-term risk stratification for survivors of acute coronary syndromes. J Am Coll Cardiol 2001; 38: 56-63.
23. Simes JR, Marschener IC, Hunt D, et al, on behalf of the LIPID Study Investigators. Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels? Circulation 2002; 105: 1162-1169.
24. Vale M, Jelinek M, Best JD, Santamaria JD. Coaching patients with coronary heart disease to achieve the target cholesterol: a method to bridge the gap between evidence-based medicine and the "real world" - randomized controlled trial. J Clin Epidemiol 2002; 55: 245-252.
25. Redfern J, EIlis E, Briffa T, Freedman SB. Modular prevention of heart disease following acute coronary syndrome (ACS) [ISRCTN42984084]. BMC Cardiovasc Disord 2006; 6: 26.